TY - JOUR
T1 - Protein kinase Cμ plays an essential role in hypertonicity-induced heat shock protein 70 expression
AU - Lim, Yun Sook
AU - Lee, Jae Seon
AU - Huang, Tai Qin
AU - Seo, Jeong Sun
PY - 2008/12/31
Y1 - 2008/12/31
N2 - Heat shock protein 70 (HSP70), which evidences important functions as a molecular chaperone and anti-apoptotic molecule, is substantially induced in cells exposed to a variety of stresses, including hypertonic stress, heavy metals, heat shock, and oxidative stress, and prevents cellular damage under these conditions. However, the molecular mechanism underlying the induction of HSP70 in response to hypertonicity has been characterized to a far lesser extent. In this study, we have investigated the cellular signaling pathway of HSP70 induction under hypertonic conditions. Initially, we applied a variety of kinase inhibitors to NIH3T3 cells that had been exposed to hypertonicity. The induction of HSP70 was suppressed specifically by treatment with protein kinase C (PKC) inhibitors (Gö6976 and GF109203X). As hypertonicity dramatically increased the phosphorylation of PKCμ, we then evaluated the role of PKCμ in hypertonicity-induced HSP70 expression and cell viability. The depletion of PKCμ with siRNA or the inhibition of PKCμ activity with inhibitors resulted in a reduction in HSP70 induction and cell viability. Tonicity-responsive enhancer binding protein (TonEBP), a transcription factor for hypertonicity-induced HSP70 expression, was translocated rapidly into the nucleus and was modified gradually in the nucleus under hypertonic conditions. When we administered treatment with PKC inhibitors, the mobility shift of TonEBP was affected in the nucleus. However, PKCμ evidenced no subcellular co-localization with TonEBP during hypertonic exposure. From our results, we have concluded that PKCμ performs a critical function in hypertonicity- induced HSP70 induction, and finally cellular protection, via the indirect regulation of TonEBP modification.
AB - Heat shock protein 70 (HSP70), which evidences important functions as a molecular chaperone and anti-apoptotic molecule, is substantially induced in cells exposed to a variety of stresses, including hypertonic stress, heavy metals, heat shock, and oxidative stress, and prevents cellular damage under these conditions. However, the molecular mechanism underlying the induction of HSP70 in response to hypertonicity has been characterized to a far lesser extent. In this study, we have investigated the cellular signaling pathway of HSP70 induction under hypertonic conditions. Initially, we applied a variety of kinase inhibitors to NIH3T3 cells that had been exposed to hypertonicity. The induction of HSP70 was suppressed specifically by treatment with protein kinase C (PKC) inhibitors (Gö6976 and GF109203X). As hypertonicity dramatically increased the phosphorylation of PKCμ, we then evaluated the role of PKCμ in hypertonicity-induced HSP70 expression and cell viability. The depletion of PKCμ with siRNA or the inhibition of PKCμ activity with inhibitors resulted in a reduction in HSP70 induction and cell viability. Tonicity-responsive enhancer binding protein (TonEBP), a transcription factor for hypertonicity-induced HSP70 expression, was translocated rapidly into the nucleus and was modified gradually in the nucleus under hypertonic conditions. When we administered treatment with PKC inhibitors, the mobility shift of TonEBP was affected in the nucleus. However, PKCμ evidenced no subcellular co-localization with TonEBP during hypertonic exposure. From our results, we have concluded that PKCμ performs a critical function in hypertonicity- induced HSP70 induction, and finally cellular protection, via the indirect regulation of TonEBP modification.
KW - HSP70 heat-shock proteins
KW - NFAT5 protein, human
KW - Protein kinase C
KW - Protein kinase inhibitors
UR - https://www.scopus.com/pages/publications/61849136736
U2 - 10.3858/emm.2008.40.6.596
DO - 10.3858/emm.2008.40.6.596
M3 - Article
C2 - 19116445
AN - SCOPUS:61849136736
SN - 1226-3613
VL - 40
SP - 596
EP - 606
JO - Experimental and Molecular Medicine
JF - Experimental and Molecular Medicine
IS - 6
ER -